Intratumoral T cell activation kills tumors regardless of T cell specificity.

Intratumoral T cell activation can eliminate tumors without tumor-specific T cell receptor involvement, relying solely on paracrine signaling and innate immune responses.

• Why it matters: This challenges the prevailing view that effective immunotherapy requires tumor-specific T cells, highlighting a potential alternative mechanism for tumor eradication that could broaden treatment strategies.
• What they did: The study activated unexhausted bystander non-tumor-specific T cells within tumors in mice, observing tumor elimination through innate leukocyte recruitment and effector molecules, without conventional TCR recognition.
• The result: This activation induced caspase-dependent tumor cell death via interferon-γ, tumor necrosis factor, and nitric oxide, with gene signatures predicting human melanoma survival, suggesting a new immunotherapy paradigm.